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Summary 
We have addressed the restriction elements involved in the interaction of lamina propria lymphocytes 
(LPL) and intestinal  epithelial cells using the model of primary mixed cell culture reaction.  Whereas 
peripheral  blood T  cells  proliferate  in  response  to  both  allogeneic  non  T  cells  and  class  II 
antigen-bearing  intestinal epithelial cells (non T  cells >> epithelial cells),  LP T  cells appear to 
proliferate preferentially in response to intestinal epithelial cells. The interaction between these 
cells does not appear to be restricted by conventional products of the major histocompatibility 
complex as neither monoclonal antibodies to class I nor to class II antigens inhibit  the mixed 
cell cultures,  whereas they are inhibitory in conventional mixed lymphocyte reactions.  Furthermore, 
treatment of epithelial cells with interferon 3/fails to augment the cells' ability to induce proliferation 
of LPL while successfully enhancing proliferation of peripheral blood T cells in parallel  cultures. 
Taken together, these data suggest that alternate restriction elements or mucosa-specific accessory 
molecules may exist on intestinal epithelial cells that are preferentially recognized by LPLs. Such 
a distinct regulatory network may be critical to the maintenance  of immunologic homeostasis 
in  the gut. 
p revious studies from several groups have clearly documented 
that nonlymphoid cells are capable of expressing class II 
Ags and,  in some settings,  can function  as effective APCs 
(1-6).  Such is the case for normal  intestinal  epithelial cells 
(IECs) 1 in mice (7), rats (8-10), and humans (11-12).  How- 
ever, in contrast to conventional APCs, normal IECs appear 
to selectively activate suppressor T cells. Whereas prostaglan- 
dins have been implicated in some forms of epithelial cell-in- 
duced suppression (10), the actual mechanisms of suppressor 
T cell induction and function are unclear.  We have recently 
reported that suppressor T cell activation in epithelial cell-T 
cell interactions may be mediated by novel stimulatory path- 
ways (13). To identify whether there might be a physiologic 
basis for these findings, we studied the interactions of isolated 
lamina propria lymphocytes (LPLs) with  intestinal  epithe- 
lium in mixed cell cultures. LPLs are an unusual cell popula- 
tion. They have been reported to be capable of proliferation 
in response to conventional mitogens and alloantigens,  but 
generally fail to proliferate in response to specific Ag (14, 15). 
Rather, they respond in Ag-specific systems by the secretion 
of cytokines. LPLs,  in contrast  to peripheral blood (PB) T 
cells, are activated memory T ceils, expressing CD45RO as 
well as a number of activation Ags, and possess significant 
1 Abbreviations used in  this paper: CD,  Crohffs disease; CM, complete 
medium; IBD, inflammatory  blood disease; IEC, intestinal epithelial cell; 
LPL, lamina propria lymphocyte; UC, ulcerative colitis. 
Th cell activity (16-18).  Their lack of proliferation  to Ag 
may relate to either an already activated state or alternatively, 
the requirement  for distinct  accessory signals.  The data in 
this paper suggest that, in contrast to PB T cells, a non class 
I or II Ag is recognized by LPL T  cells,  resulting in both 
activation  and proliferation. 
Materials  and Methods 
Specimens.  Surgical  specimens from patients undergoing bowel 
resection for cancer (10 cm away from tumor), Crohn's  disease, 
ulcerative colitis, or other inflammatory diseases at the Mount Sinai 
Hospital,  were used as a source of epithelial cells, intraepithelial 
lymphocytes (IELs), and LPLs. 
Isolation of PB T and Non T  Cells.  Heparinized venous blood 
was obtained from normal donors, diluted 1:2 with PBS, and sepa- 
rated by Ficoll-Hypaque (Pharmacia, Piscataway, NJ) density gra- 
dient centrifugation  to obtain isolated PBMC. Further separation 
of mononuc|ear  cells into T and non T cell populations was per- 
formed by rosetting with sheep erythrocytes as previously described 
(19). Monocytes and dendritic cells  were isolated by plastic adherence. 
Isolation of  LPLs.  The method used to isolate LPLs was a modi- 
fication of the original technique of Bull and Bookman (20). Briefly, 
surgical specimens were rinsed in PBS vigorously to remove loosely 
adherent material, and then gently rubbed with sterile gauze. The 
mucosa was then stripped offby careful dissection from the under- 
lying sub-mucosa, minced, washed several times in calcium mag- 
nesium-free HBSS (CMF-HBSS) containing 1% penicilhn-strepto- 
mycin, 1% fungizone, 50 #g/ml gentamicin (all from GIBCO BRL, 
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Louis, MO). The tissue was then treated with 1 mM dithiothreitol 
(DTT, Sigma Chemical Co.) in RPMI 1640 containing 5% FCS 
(both from GIBCO BRL) for 15 min at 37~  After washing, tissue 
pieces were placed in a siliconized flask in CMF-HBSS containing 
0.75 mM EDTA (Sigma Chemical Co.) and maintained on an or- 
bital shaker (100 rotations per min) at 37~  for a total of three 
45-rain incubations. At each time interval, the tissue was washed 
with CMF-HBSS to remove the loosely bound epithelial cells and 
liberated IELs. The remaining tissue was kept in RPMI for 15 min 
and further  subjected to enzymatic digestion overnight at 37~ 
in 50 ml of antibiotic-antimycotic-supplemented RPMI containing 
0.1/xg/ml DNase, 0.1/~g/ml soybean trypsin inhibitor (both from 
Sigma Chemical Co.)  and  0.08  /~g/ml collagenase  (Boehringer 
Mannheim,  Indianapolis, IN). 
After 18 h,  digested tissues  were placed on a wire mesh and 
rubbed with a rubber policeman resulting in the liberation of lym- 
phocytes from the lamina propria. This crude cell suspension was 
pelleted and resuspended in a 15-ml conical tube in 2.5 ml of 100% 
Percoll  (Pharmacia) which had been adjusted to pH 7.4 with an 
osmolality of 290 mOsm. 2.5-ml layers of 60, 40, and 30% Percoll 
(prepared by diluting 100% Percoll with RPMI 1640) were succes- 
sively layered on top to establish the gradient. The Percoll gradient 
was centrifuged at 1,500 rpm for 35 min at 22~  and cells at the 
interface of the 60 and 40% Percoll layer were carefully collected 
to  obtain  the  purified  LPLs.  The  LPLs  were  typically  >95% 
HLe-1 § with  2-5%  contaminating epithelial cells. 
Isolation of Epithelial Cells.  Epithelial cells were obtained from 
two dispase (3 mg/ml; Boehringer Mannheim) treatments for 30 
rain each at 37~  as described previously (11). The cell suspensions 
resulting from dispase treatments were centrifuged on Percoll den- 
sity gradients similar to the isolation of LPLs. The top 0/30% layer 
interface contained >95% pure epithelial cells. Purity was confirmed 
by flow cytometric analysis (EPICs C; Coulter, Hialeah, FL) using 
anti-CD14, -CD3, -CD20, and L12 (antiepithelial  cell) mAbs. Con- 
taminating cells were predominantly CD3 § T cells (2-4%). Cells 
were washed three times in PBS, and viability was determined by 
trypan blue exclusion. For both LPLs and epithelial cells, if via- 
bility was not  >95%,  the cells were not used in the  studies. 
Mixed Cell Culture Reaction.  Allogeneic mixed cell culture reac- 
tions were performed as previously described (11) using freshly iso- 
lated LPLs (105 cells/well)  with varying numbers of irradiated ep- 
ithelial cells  or non T  cells  (1  x  105, 5  x  104, and 2.5  x  104 
cells/well) in RPMI, 5% human agammaglobulinemic serum, 1% 
penicillin-streptomycin, and 2 mM glutamine, henceforth termed 
culture medium (CM). In each study, parallel assays were performed 
using PB T cells. Control cultures of LPL or PB T cells alone (nega- 
tive control), irradiated stimulators alone (negative control), as well 
as T cells cultured in the presence of the nonspecific mitogen PHA 
(1 #g/ml, GIBCO BRL) (positive control) were included in each 
experiment.  All cultures were performed in triplicate in 96-well 
round bottom microwell tissue culture plates (Falcon, Oxnard, CA) 
for 120 h at 37~  in a 5% CO2 humidified incubator. During the 
last 18 h of culture,  1/~Ci [3H]thymidine (ICN Radiochemicals, 
Irvine, CA) was added, and cells were harvested onto glass fiber 
filter mats for counting as previously described (11) using a scintil- 
lation counter (model 3801; Beckman Instruments, Inc., Somerset, 
NJ).  Whereas the initial studies used non T  cells and epithelial 
cells from different donors (not reported here), all studies depicted 
in this article represent experiments where non T cells and IECs 
were derived from the same donor, eliminating the question of MHC 
matching of stimulator cells. Similarly,  LPLs and PB T cells were 
derived from the same individual,  allogeneic to the IEC/non T 
cells. The results under both conditions  (i.e., whether IECs and 
non T  cells were derived  from different individuals  or the same 
individual)  were comparable. 
Antibody Inhibition Studies.  All antibodies used in these studies 
were purified from ascites by protein G column chromatography 
(Pharmacia). The anti-HLA-DR mAb VG2 (IgGIK) recognizing 
nonpolymorphic determinants,  was obtained from Dr. Shu Man 
Fu (University of Virginia, Charlottesville, VA). L243 (anti-DR 
nonpolymorphic IgG1K), genox 3.53 (anti-DQ-IgG1K),  and W6/32 
(anti-class  I-IgG1K) mAbs were obtained from the American Type 
Culture Collection (Rockville, MD). The anti-DP mAb, B7/21, 
was the kind gift of Drs. Barbara Bierer and Steven Burakoff (Dana 
Farber Cancer Institute, Boston, MA). These antibodies have pre- 
viously been shown to inhibit conventional MLR cultures (anti- 
class II reagents) (21) and cytolytic T cell activation (W6/32) (22). 
One million isolated epithelial cells or non T cells were prein- 
cubated with mAbs (10/xg/106  cells) for 30 min at room temper- 
ature. This concentration was used since we had previously demon- 
strated that this was the optimal concentration for mixed cell culture 
reaction inhibition and staining. The cells were then washed three 
times in PBS, resuspended in CM, counted, and irradiated (3,000 
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Figure 1.  (.4) LPLs (from individual ^, 105 cells/well, triplicate cul- 
tures) were cocuhured with varying concentrations (105-2.5  ￿  104) of 
either normal, isolated, irradiated (3,000 rad) IECs or non T cells from 
individual ~ for 120 h. [3H]Thymidine was added during the last 18 h 
and cells were processed  for scintillation counting. (B) Similar to A except 
that PB T cells (from the same individual [A] as the LPL) are used as the 
responder population.  This figure is representative of at least five ex- 
periments. 
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the responders cells (LPLs or PB T cells) in 96-well culture plates 
as described above for mixed cell culture reactions.  The blocking 
activity of these  antibodies  was  ascertained  by comparing  the 
proliferative responses induced by the antibody treated versus the 
untreated stimulator cells. Antibodies were not added directly to 
the wells as both mAbs to class II and I Ags may be inhibitory 
for T  cell activation. 
Results 
Normal LPLs Preferentially Respond  to Epithelial  Cells in 
MLRs.  Conventional unidirectional allogeneic MLRs are 
characterized by the recognition of foreign class II Ag by al- 
loreactive T  cells. We have previously demonstrated that PB 
T  cells proliferate in response to class II Ag-bearing  intes- 
tinal epithelium (11). To determine whether the effects seen 
have potential physiologic relevance, we cocultured isolated 
LPLs (which interact with epithelial cells in vivo via fenes- 
trations in the basement membrane [23]) with either allogeneic 
epithelial cells or allogeneic non T cells (from the same donor 
as the IECs). As seen in a representative experiment (repre- 
sentative of five experiments),  normal LPL T  cells  (Fig.  1 
A), like PB T cells (Fig. 1 B), proliferate in a dose-dependent 
fashion in response to allogeneic epithelial cell stimulators. 
However, in contrast to PB T  cells (Fig. 1 B), the prolifera- 
tive response by LPLs (Fig. 1 A) to non T cells was less than 
that seen with epithelial cells. Although the ability of LPL 
to proliferate in response to non T cells was variable in different 
experiments, non T cell stimulation of LPL proliferation was 
always lower when compared with epithelial cells. Further- 
more, the source of epithelial cells did not appear to influence 
the results. Whereas epithelial cells from patients with inflam- 
matory bowel diseases (IBD) were generally more stimula- 
tory (as previously reported for PB T cultures; 24) than normal 
epithelial cells, responses to normal epithelial cells were con- 
sistently greater than those induced by non T cells. Since non 
T cells express class II Ag on their surface at greater density, 
and were matched for both class  I  and  II MHC  with  the 
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Figure 2.  (A) LP T cells (10S/well triplicate cultures) isolated from actively inflamed tissue from a patient with Crohn's disease (CD) cocultured 
in MLR cultures with allogeneic epithelial cells (10  s) or non T cells (los). (B) LP T cells (los/well triplicate cultures) isolated from uninflamed tissue 
from a patient with Crohffs disease (CD) cocultured in MLIk cultures with allogeneic  epithelial cells (105) or non T cells (10s). (C) LP T cells (10S/well 
triplicate cultures) isolated from actively  inflamed  tissue from a patient with ulcerative  colitis (UC) cocultured in MLR cultures with allogeneic  epithelial 
cells (10  s) or non T cells (105). (D) T cells (10S/well triplicate cultures) isolated from uninflamed tissue from a patient with ulcerative colitis (UC) 
cocuhured in MLR cultures with allogeneic epithelial cells (10  s) or non T cells (105). Proliferation was assessed as described in Fig. 1. This figure 
is representative of at least 10 experiments. 
945  Panja et al. epithelial cells, these data suggest that LPLs are recognizing 
a non class II Ag determinant on epithelial cells. 
The preferential proliferation in response to epithelial cells 
was seen regardless  of whether the LP T cells were derived 
from normal or IBD bowel. As seen in Fig.  2,  LP T  cells 
derived from Crohn's Disease (CD) (inflamed, A, uninflamed, 
B) or ulcerative colitis (UC) (inflamed, C, uninflamed, D), 
all preferentially proliferate in response to isolated epithelial 
cells regardless  of whether the epithelial cells were derived 
from IBD  or normal tissues. 
One recognized difference between PB and LP T cells is 
that LPLs are enriched for memory and activated T cells (15). 
It is plausible,  therefore, that the findings described  above 
may relate to the recognition of luminal Ags that are bound, 
in vivo, to classical restriction elements on isolated epithelial 
cells. Given the heterogeneity of class I or II molecules, LPLs 
may be recognizing luminal Ags in the context of matched 
MHC molecules carried on IECs. Since we did not deter- 
mine the MHC haplotypes of the cells studied, it is conceiv- 
able that appropriate Ag presentation through appropriate 
MHC is occurring in these cultures. To address  this more 
directly, we performed an autologous mixed cell culture reac- 
tion using LP and PB T cells cocultured with either epithe- 
lial cells or non T cells from the same individual. If memory 
T cell activation was occurring in the LPL-epithelial cell in- 
teractions via presentation of luminal Ags, we would see an 
enhanced autologous mixed cell culture reaction in these cul- 
tures, but not in the non T cell-driven cultures. As seen in 
Fig.  3, proliferation of either LPLs or PB T  cells occurred 
in the allogeneic cultures only, and no enhancement of the 
autologous mixed cell culture reaction was seen. Since this 
experiment maximizes the chances  of appropriate memory 
T cell activation, it is unlikely that the results in the allogeneic 
system reflect  such a scenario.  Furthermore, these findings 
speak against the solitary role of an adhesion molecule to ex- 
plain the observations described above. 
One possible explanation for our findings could be that 
the isolation procedure used to purify LPLs had altered their 
ability to respond to non T cells. Although this should not 
account for the difference between epithelial cells and non 
T  cells, it may reflect an alteration of recognition elements 
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Figure  3.  LPL  (10  S) or  PB  T  cells  (105) isolated  from  the  same in- 
dividual were cocultured with either irradiated autologous or allogeneic 
epithelial cells (10s).  Proliferation was assessed as described in Fig.  1. This 
figure is representative of three experiments. 
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Figure  4.  PB T  cells were subjected to the same isolation procedure 
as that described for LPL (EDTA,  DNAse,  collagenase) and cocultured 
with allogeneic non T  cells as described in Fig.  1. No  significant effect 
of collagenase is seen. This figure is representative of two experiments. 
on LP T cells. To address this issue, we subjected PB T cells 
to the same isolation protocol used for LPLs. The enzyme- 
treated T cells were still capable of responding (slight reduc- 
tion of<20%) to non T cells (Fig. 4) in an allogeneic MLR. 
Antibodies  to Class HAgs Fail to Inhibit LPL Response to 
Epithelial Cells.  We have previously shown that antibodies 
to class II molecules inhibit epithelial cell-stimulated PB T 
cell MLR responses (11) when added directly to the culture 
well. Since non T cells fail to stimulate LPLs effectively, we 
wanted to determine whether LPLs were recognizing a non 
class II Ag on epithelial cells. Epithelial cells from normal 
individuals or patients with CD or UC were incubated with 
varying concentrations of the anti-DR mAb VG2  (10-0.1 
/~g/ml) for 30 min. After washing, the epithelial cells were 
cocultured with either LP or PB T cells in CM. In a repre- 
sentative set of experiments, the anti-DR pretreatment, but 
not an isotype-matched control mAb (data not shown), effec- 
tively inhibited the PB T cell response to CD epithelial cells 
and non T cells (Fig. 5 A). This same anti-DR mAb treat- 
ment, however, failed to block the LPL response  (Fig. 5 B) 
to the same epithelial cells. In the experiment shown, since 
non T cell stimulation of LPLs was weak to start with, the 
anti-DR mAb treatment had little effect in these cultures. 
However, in other experiments where non T  cell stimula- 
tion was evident, VG2 could inhibit LPL proliferation, al- 
though not completely. We further analyzed the role of class 
II Ags in these cultures by pretreating the IECs with anti- 
bodies to DQ (genox 3.53),  DP (B7/21),  and/or an addi- 
tional anti-DR mAb (L243).  These antibodies have previ- 
ously been shown to inhibit conventional MLR cultures (21). 
As seen in Fig. 6, none of these antibodies, alone or in com- 
bination, inhibited LPL stimulation by IECs.  Stimulation 
could be inhibited by the antiepithelial cell mAb L12 previ- 
ously defined for this property (25). These data support the 
concept that LPLs recognize a non class II determinant on 
epithelial cells, whereas PB T cells recognize class II Ags at 
least  on IBD epithelium. 
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Figure 5.  Epithelial cells (10  s) from patients with CD were incubated 
with the anti-DR mAb VG2, an IgG1 isotype control (data not shown), 
or medium alone for 30 min at 4~  and washed three times in PBS to 
remove unbound  mAb. Treated and untreated  epithelial cells were then 
cocultured with LPL (10 5) (.4) or PB T  cells (10 s) (B) in MLR cultures. 
Proliferation was assessed as described in Fig. 1. No inhibition by the IgG1 
mAb was seen in any culture.  This figure is representative of at least 10 
experiments. 
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Figure  7.  Isolated epithelial cells  (10 s) were cocuhured with  IFN-7 
(250 U/ml) for 18 h, washed, irradiated 3,000 rad, and cocultured with 
either LPL (105) or PB T  cells (10  s) for 120 h.  Proliferation was assessed 
as described in Fig.  1.  This figure is representative of two experiments. 
IFN-7 Fails to Upregulate or Alter the LPL Response to Epi- 
thelial Cells.  IFN-'y is known to upregulate class II Ag ex- 
pression on lymphoid cells (26) as well as on epithelium (27, 
28).  We cultured epithelial  cells in  the presence of IFN-3' 
(250 U/ml)  for 18-24 h before use as stimulators in mixed 
cell cultures. We have previously shown that this concentra- 
tion is effective at enhancing expression class II Ags on these 
cells  (28).  As  seen in Fig.  7,  despite  IFN-y  treatment,  no 
change in the proliferative response by LPLs was demonstrable. 
In parallel  cultures, however,  the response to these cells by 
PB T cells was augmented by IFN-% These data provide fur- 
ther support for a non dass II Ag stimulator molecule present 
on normal and IBD  epithelial  cells. 
Discussion 
Despite the expression of class  II Ags  on normal IECs 
(7-12),  IEC fail to function in a manner similar to that of 
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Figure  6.  Normal epithelial cells  (105  ) 
were incubated  with  the  anti-DR  mAb 
VG2 (anti-DR [A]), or L243 (anti-DR [B]), 
anti-DQ mAb genox 3.53, anti-DP mAb 
B7/21,  alone or in combination,  the an- 
tiepithelial cell mAb L12, or medium alone 
for 30 min at 4~  and washed three times 
in PBS to remove unbound mAb. Treated 
and  untreated  epithelial  cells  were  then 
cocuhured with LPL (10  s) in mixed cell 
cultures.  Proliferation was assessed  as de- 
scribed in Fig. 1. No inhibition by an IgG1 
control mAb was seen in any culture. This 
figure is representative  of three experiments. conventional APC. Whereas they are capable of inducing pro- 
liferation of alloreactive T cells in peripheral blood, in humans 
they appear to selectively activate  CD8 § Ag-nonspecific sup- 
pressor cells (11). This suggests that unique differences exist 
between monocytes/macrophages/dendritic cells and intestinal 
epithelium.  In this study, we document that LPLs are also 
capable of recognizing  allogeneic epithelial  cells  (inducing 
proliferation),  but in contrast  to conventional MLRs,  this 
effect does not  appear  to be regulated  via classical  class  II 
Ag-TCR interactions. First, LPLs proliferate better to epithe- 
lial cells than to conventional MLR stimulators (macrophage/ 
dendritic cells) from the same individual. Second, antibodies 
to class II Ags (DR,  DP, DQ),  singly or in combination, 
fail to inhibit LPL proliferation.  Furthermore,  upregulation 
of class II Ags by IFN-y fails to alter the response of LPLs 
to IECs. Other investigators have documented that LPLs are 
distinct  from circulating  T  cells.  Whereas  they proliferate 
in response to mitogens,  they fail to proliferate in response 
to specific Ags (15), even when primed.  In this setting,  the 
Ag receptor appears to be intact since Ag-specific stimulation 
does induce the production of cytokines. It is presumed that 
the Ag in these studies is presented to LPLs by tissue macro- 
phages or dendritic cells. However, no specific assessment of 
LPL-epithelial cell interactions  has been performed to date. 
Our  initial  studies using normal  IECs as APCs revealed  a 
selective activation of CD8 § PB T cells by normal epithelial 
cells. This finding appears to represent the presence of an al- 
ternate stimulatory pathway for T cell activation. In a more 
physiologic system, LPLs and epithelial ceils, this effect may 
be magnified.  There is a reversal  in the response pattern  to 
allogeneic stimulators  cells by PB T  cells  (non T  cells  >> 
epithelial cells)  when compared with LP T  cells (epithelial 
cells >> non T cells).  As yet, we have been unable to docu- 
ment either  the T  cell subpopulations  that  are  specifically 
proliferating in these cultures, or whether anti-CD8  mAbs 
are inhibitory.  These studies  are currently  in progress. 
Mixed lymphocyte reactivity is generally reflective of a re- 
sponse to a polymorphic product  of the MHC.  Typically, 
the response by alloreactive T  cells is directed against a for- 
eign class II molecule that may be perceived as self plus Ag 
(29). Alternative stimulatory molecules have not been clearly 
defined. From our studies it is clear that the response to epi- 
thelial cells is not class I (25) or II Ag related since non T 
cells bearing the same surface MHC (albeit in varying densi- 
ties) are either less or nonstimulatory. In addition, one cannot 
explain our data by invoking classical Ag presentation since 
autologous class II Ag-bearing epithelial cells fail to activate 
LPLs to a level comparable with that of allogeneic epithelial 
cells. The stimulatory molecule in LPL-epithelial cell MLRs 
would, like class I or II Ags, have to be polymorphic since 
a common stimulatory molecule, such as one stimulating via 
CD2,  would result in the stimulation  of both  autologous 
and allogeneic cells.  In our studies,  only stimulation  of al- 
logeneic cells is seen. Novel polymorphic determinants would 
therefore need to be proposed. Several possibilities exist. First 
there is growing evidence that heat shock proteins can bind 
peptide Ags and, if expressed on the cell surface,  may serve 
as restriction  elements for immune  responses (30).  In fact 
there  have been  numerous  reports  of IELs  capable  of re- 
sponding to mycobacterial heat shock protein (31). Second, 
other molecules of potential interest include the class I-like 
molecule CDld which has been recently identified on mu- 
rine and human epithelium (32, 33). Whereas CDld is not 
polymorphic, its similarity to class I Ag may render it capable 
of serving as a restriction element.  Using mAbs to CDld, 
we have been able to inhibit PB T cell-normal epithelial cell 
MLRs (34).  However, this mAb failed  to inhibit LPL-IEC 
mixed cell cultures (34). Third, in an attempt to define a novel 
restriction element, we have generated a series of mAhs against 
epithelial cell surface Ags (B9, B39, L12,  and K3) that are 
capable of inhibiting epithelial cell-PB T cell interactions  (25). 
A dual stimulatory pathway (for CD8 + T cell and alloreac- 
tive cells) may help to explain the selective antigen-nonspecific 
CD8 + T  cell proliferation induced by epithelial cells in the 
PB T  cell cultures  (12) and the Ag specificity seen  in oral 
tolerance (LPL-epithelial cell novel restriction element inter- 
action). Fourth, epithelial cells may express endogenous su- 
perantigens  equivalent to Mls in the mouse. Superantigens 
have the property of expanding specific T cell subpopulations 
by binding to class II molecules and stimulating  selected T 
cell Ag receptors (35).  Endogenous or exogenous superan- 
tigens might display a preference for LPL T cells or demon- 
strate selection for alloreactive LPL. However, we have re- 
cently demonstrated  that  IECs  do not  selectively activate 
specific V/3 T cell subpopulations in mixed cell culture systems 
(36).  Finally,  the response seen may reflect  the presence of 
some adhesion molecule, expressed on IECs, whose ligand 
is uniquely present on mucosal lymphocytes (i.e.,  HML-1). 
The likelihood of this last possibility is reduced by the fact 
that proliferation was seen only in allogeneic systems, sup- 
porting the existence of a polymorphic determinant.  Studies 
to explore each of these scenarios are  the current  focus of 
the laboratory. 
In contrast to LPLs, we are unable to demonstrate induc- 
tion of proliferation of IELs by allogeneic epithelial cells (data 
not shown). We are, however, using an allogeneic mixed cell 
culture system so that the data generated with LPLs or IELs 
may not truly reflect  the interactions  required for antigen- 
specific  responses.  Such  studies  are  difficult to perform  in 
humans  since parenteral immunization  would not result in 
T cell priming in the GI tract and oral priming may not re- 
sult in activation of T cells at an accessible site (i.e., resection 
site).  Directed immunization  would be required to address 
this  tissue. 
Alternate pathways of T  cell activation have been clearly 
defined.  These include stimulation  via CD2 and accessory 
stimulation via CD28, CD45, CD4, and CD8 (37-39). We 
have proposed that cross-linking CD8 by a novel ligand on 
epithelial cells may result in the activation and proliferation 
of these cells.  However, many of the activation  stimuli do 
not function in a vacuum, and it is conceivable that coactiva- 
tion events (mucosa-specific  adhesion molecules) are required. 
Our  system provides an  avenue to explore such activation 
events. Whereas several alternate activation pathways for T 
948  Selective  Activation of LPL by Intestinal Epithelial Cells cells have been described, it is not clear whether one of these 
pathways, or alternatively a novel pathway, is involved in LPL 
activation.  Such differences could explain the unique envi- 
ronment of the intestinal  tract and much of the phenome- 
nology,  such  as  oral tolerance,  that  is associated with  it. 
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